GenMark Diagnostics (GNMK) Sell-Off Buying Opp., Agreement Intact - Canaccord
Tweet Send to a Friend
Canaccord Genuity today maintained a Buy rating on GenMark Diagnostics (NASDAQ: GNMK) with a price target of $18.00. This morning ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
